Fertility preservation methods in young women with systemic lupus erythematosus prior to cytotoxic therapy: experiences from the FertiPROTEKT network
Publisher DOI
PubMed ID
22438026
Abstract
Despite new treatment options, some patients with systemic lupus erythematosus (SLE) need to be treated with the cytotoxic agent cyclophosphamide (CYC). Unlike malignant disease, there are no recommendations for ovarian protection in SLE. The clinical experience of the FertiPROTEKT network as well as recommendations after literature review will be presented in this paper.
Date Issued
2012
Publication Type
Article
Language(s)
en
Author(s)
Henes, M | |
Henes, J C | |
Neunhoeffer, E | |
Schmalzing, M | |
Kötter, I | |
Lawrenz, B |
Additional Credits
Journal
Lupus
Publisher
Sage
ISSN
0961-2033
Access(Rights)
metadata.only